What's new

Human medicines European public assessment report (EPAR): Lyumjev (previously Liumjev), insulin lispro, Date of authorisation: 24/03/2020, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Lyumjev (previously Liumjev), insulin lispro, Date of authorisation: 24/03/2020, Revision: 7, Status: Authorised

Feb 14, 2025 - 13:46
 0
Human medicines European public assessment report (EPAR): Lyumjev (previously Liumjev), insulin lispro, Date of authorisation: 24/03/2020, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Lyumjev (previously Liumjev), insulin lispro, Date of authorisation: 24/03/2020, Revision: 7, Status: Authorised
Read More

Tags:

Previous Article

Jigsaw CEO to exit after just 15 months

Next Article

How To Talk to Talk About Money With Kids ​(Without Scaring Them)

Related Posts

Human medicines European public assessment report (EPAR): Neupro, rotigotine, Date of authorisation: 15/02/2006, Revision: 35, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 19, 2025  0

EMA Open Door Day, European Medicines Agency, Amsterdam, the Netherlands, from 9 May 2025, 09:00 (CEST) to 9 May 2025, 16:45 (CEST)

EMA Open Door Day, European Medicines Agency, Amsterdam...

Feb 9, 2025  0

EMEA-003301-PIP01-22-M01

EMEA-003301-PIP01-22-M01

Feb 17, 2025  0